البلد: سنغافورة
اللغة: الإنجليزية
المصدر: HSA (Health Sciences Authority)
ORLISTAT
DKSH SINGAPORE PTE. LTD.
A08AB01
120MG
CAPSULE
ORLISTAT 120MG
ORAL
Pharmacy Only
F. Hoffman-La Roche Ltd
ACTIVE
2005-01-31
1 XENICAL ® CAPSULE 120 MG PATIENT INFORMATION LEAFLET Please read this leaflet carefully because it contains important information for you. If you want to know more about this product, or if you are not sure about a particular item in the leaflet please ask your doctor or pharmacist. WHAT IS IN THIS LEAFLET? • This leaflet answers some common questions about XENICAL capsules. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. • If you have any concerns about taking this medicine, ask your doctor or pharmacist. • Keep this leaflet with the medicine. You may need to read it again. WHAT IS XENICAL ® ? Each XENICAL capsule contains 120 mg of the active substance orlistat. The capsule also contains the additional excipients microcrystalline cellulose, sodium starch glycollate, povidone, sodium lauryl sulphate and talc. The capsule shell consists of gelatin, indigo carmine (E132), titanium dioxide (E171) and edible printing ink. XENICAL is supplied as hard capsules in blister packs. WHAT IS XENICAL ® TAKEN FOR? XENICAL is used to treat people who are obese with a body mass index (BMI) greater or equal to 30 kg/m 2 , or overweight patients (BMI greater or equal to 28 kg/m 2 ) with obesity-related risk factors. Your Body Mass Index (BMI) is calculated by dividing your weight (in kg) by your height (in metres) squared. Treatment with XENICAL should be discontinued after 12 weeks if you are unable to lose at least 5% of your body weight as measured at the start of drug therapy. XENICAL belongs to a group of medicines called lipase inhibitors. XENICAL targets the absorption of fat in your body rather than suppressing your appetite. Dietary fats are large molecules which need to be broken down by enzymes called lipases before they can be absorbed into the body. When taken with a meal, XENICAL interferes with the activity of these enzymes. This allows about 30% of the fat eaten in the meal to pass through the gut undigested. Your body therefore cann اقرأ الوثيقة كاملة
1 XENICAL ® ORLISTAT 1. PHARMACEUTICAL FORM XENICAL 120 mg hard capsules. The capsule has a turquoise cap and turquoise body bearing the imprint of “XENICAL 120”. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 120 mg orlistat. For excipients, see section 5.1. 3. CLINICAL PARTICULARS 3.1 THERAPEUTIC INDICATIONS Xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m 2 , or overweight patients (BMI ≥ 28 kg/m 2 ) with associated risk factors. Treatment with Xenical should be discontinued after 12 weeks if patients have been unable to lose at least 5% of their body weight as measured at the start of drug therapy. In type 2 diabetic patients who are overweight (BMI ≥ 28kg/m 2 ) or obese (BMI ≥ 30kg/m 2 ), clinical studies conducted over one year showed Xenical, in conjunction with a mildly hypocaloric diet, provides additional glycemic control when used in combination with anti-diabetic agents such as metformin, sulfonylurea and/or insulin. No studies have been done in patients receiving concomitant treatment with thiazolidinedione. The efficacy of Xenical as a monotherapy treatment for type 2 diabetes has not been established. 3.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended dose of orlistat is one 120 mg capsule taken with water immediately before, during or up to one hour after each main meal. If a meal is missed or contains no fat, the dose of orlistat should be omitted. The patient should be on a nutritionally balanced, mildly hypocaloric diet that contains approximately 30 % of calories from fat. It is recommended that the diet should be rich in fruit and vegetables. The daily intake of fat, carbohydrate and protein should be distributed over three main meals. Doses of orlistat above 120 mg three times daily have not been shown to provide additional benefit. The effect of orlistat results in an increase in faecal fat as early as 24 to 48 hours after dosing. Upon disc اقرأ الوثيقة كاملة